Your browser doesn't support javascript.
loading
Bendamustine-based conditioning prior to autologous stem cell transplantation (ASCT): Results of a French multicenter study of 474 patients from LYmphoma Study Association (LYSA) centers.
Chantepie, Sylvain P; Garciaz, Sylvain; Tchernonog, Emmanuelle; Peyrade, Frederic; Larcher, Marie-Virginie; Diouf, Momar; Fornecker, Luc-Mathieu; Houot, Roch; Gastinne, Thomas; Soussain, Carole; Malak, Sandra; Lemal, Richard; Delette, Caroline; Ibrahim, Ahmad; Gac, Anne-Claire; Reboursière, Emilie; Vilque, Jean-Pierre; Bekadja, Mohamed-Amine; Casasnovas, Rene-Olivier; Gressin, Remy; Guidez, Stéphanie; Coso, Diane; Herbaux, Charles; Yakoub-Agha, Ibrahim; Bouabdallah, Krimo; Durot, Eric; Damaj, Gandhi.
Afiliação
  • Chantepie SP; Institut d'Hématologie de Basse-Normandie, CHU, Caen, France.
  • Garciaz S; Department of Hematology, Institut Paoli Calmettes, Marseille.
  • Tchernonog E; Department of Clinical Hematology, University Hospital Montpellier, Montpellier, France.
  • Peyrade F; Hematology Department, Centre Antoine Lacassagne, Nice, France.
  • Larcher MV; Hematology, Toulouse University Hospital, Toulouse, France.
  • Diouf M; Clinical Research Department, Amiens University hospital, Amiens, EA4666, France.
  • Fornecker LM; Haematology, University Hospital, Strasbourg, France.
  • Houot R; Hematology, University hospital, Rennes, France.
  • Gastinne T; Department of Hematology, Nantes University Hospital, Nantes, France.
  • Soussain C; Department of Hematology, Curie Institute, Hôpital René Huguenin, Saint-Cloud, France.
  • Malak S; Department of Hematology, Curie Institute, Hôpital René Huguenin, Saint-Cloud, France.
  • Lemal R; Service d'hématologie clinique adulte et de thérapie cellulaire, CHU ESTAING, EA 7453 CHELTER, Université Clermont Auvergne CIC-501, Clermont-Ferrand, France.
  • Delette C; Oncopole Hopital Sud, Amiens, FRA.
  • Ibrahim A; Makassed General Hospital, Beirut, LBN.
  • Gac AC; Institut d'Hématologie de Basse-Normandie, CHU, Caen, France.
  • Reboursière E; Institut d'Hématologie de Basse-Normandie, CHU, Caen, France.
  • Vilque JP; Institut d'Hématologie de Basse-Normandie, Centre François Baclesse, Caen, France.
  • Bekadja MA; Hematology and Cell Therapy, Etablissement Hospitalier Universitaire (EHU) 1st November, Oran, Algeria.
  • Casasnovas RO; Hematology, University Hospital, Dijon, France.
  • Gressin R; Hematology, CHU Grenoble, Grenoble, France.
  • Guidez S; Oncologie hématologique et thérapie cellulaire, CHU Poitiers, Poitiers, France.
  • Coso D; Department of Hematology, Institut Paoli Calmettes, Marseille.
  • Herbaux C; Hematology, Hôpital HURIEZ UAM allogreffe de CSH, CHRU, Lille, France.
  • Yakoub-Agha I; Hematology, Hôpital HURIEZ UAM allogreffe de CSH, CHRU, Lille, France.
  • Bouabdallah K; Haematology, CHU de Bordeaux, Bordeaux, France.
  • Durot E; Department of Hematology, Centre Hospitalier Universitaire, Reims Cedex, FRA.
  • Damaj G; Institut d'Hématologie de Basse-Normandie, CHU, Caen, France.
Am J Hematol ; 93(6): 729-735, 2018 Jun.
Article em En | MEDLINE | ID: mdl-29473209
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Cloridrato de Bendamustina / Linfoma Idioma: En Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Cloridrato de Bendamustina / Linfoma Idioma: En Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França